2017 ASH Meeting on Hematologic Malignancies

Description

Access recorded presentations and panel discussions from the 2017 ASH Meeting on Hematologic Malignancies to hear the top experts in the field discuss the latest developments in clinical care and provide insights into how they treat their patients.

The 2017 ASH Meeting on Hematologic Malignancies was supported by educational grants from:

• AbbVie, Inc.
• Agios Pharmaceuticals
• Amgen, Inc.
• Astellas Pharma
• AstraZeneca
• Bristol-Myer Squibb
• Celgene Corporation
• Gilead Sciences, Inc.
• Incyte Corporation
• Jazz Pharmaceuticals
• Merck & Co.
• Novartis Pharmaceuticals, Inc.
• Pfizer, Inc.
• Pharmacyclics
• Seattle Genetics
• Takeda Oncology
• Teva Oncology

Pricing

Member Type Price
List Price $275.00
Active, International, Emeritus, and Honorary Members $100.00
Associate, International Associate, Student, and Resident Members $75.00

Sessions

back to top